Sakar Healthcare (SAKAR) Stock Overview

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. It provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. The company's product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. It also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. The company was incorporated in 2004 and is based in Ahmedabad, India.

SAKAR Stock Information

Symbol

SAKAR

Address

406, Silver Oaks Comm. ComplexAhmedabad, 380007India

Founded

Trading hours

Website

https://www.sakarhealthcare.com

Country

🇮🇳 India

Phone Number

91 79 2658 4655

Sakar Healthcare (SAKAR) Price Chart

Sakar Healthcare Overview: Key Details and Summary

Stock data	2023	Change
Price	$3.91	N/A
Market Cap	$72.61M	N/A
Shares Outstanding	18.59M	23.13%
Employees	297.00	N/A
Shareholder Equity	1.73B	36.01%

Valuation	2023	Change
P/E Ratio	0.57	N/A
P/S Ratio	4.56	N/A
P/B Ratio	0.04	N/A

Growth	2023	Change
Return on Equity	0.0009	N/A

Earnings	2023	Change
Revenue	$15.92M	N/A
Earnings	$1.52M	N/A
EPS	6.86	N/A
Earnings Yield	1.76	N/A
Gross Margin	0.4467	N/A
Operating Margin	0.1433	N/A
Net income margin	0.0957	N/A

Financial Strength	2023	Change
Total Assets	$40.15M	N/A
Total Debt	$14.23M	N/A
Cash on Hand	$420.48K	N/A
Debt to Equity	0.0112	-14.59%
Cash to Debt	0.0296	-61.54%
Current Ratio	$1.03	-4.05%